Sanofi (SNYNF)
| Previous close | 101.50 |
| Open | 101.50 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 101.50 - 101.50 |
| 52-week range | 86.12 - 110.45 |
| Volume | |
| Avg. volume | 26,596 |
| Market cap | 126.834B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 26.09 |
| EPS (TTM) | 3.89 |
| Earnings date | 25 July 2024 |
| Forward dividend & yield | 4.06 (4.00%) |
| Ex-dividend date | 13 May 2024 |
| 1y target est | N/A |
ZacksDenali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
Denali (DNLI) Q1 loss narrows year over year due to lower expenses despite nil revenues.
GuruFocus.comSanofi SA's Dividend Analysis
Sanofi SA (NASDAQ:SNY) recently announced a dividend of $2.04 per share, payable on 2024-06-06, with the ex-dividend date set for 2024-05-09. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Sanofi SAs dividend performance and assess its sustainability.
BloombergBofA, BNP Poised to Win Lead Roles on $20 Billion Sanofi Spinoff
(Bloomberg) -- Bank of America Corp. and BNP Paribas SA are on the verge of winning lead roles arranging Sanofi’s separation of its consumer-health business, according to people familiar with the matter, in one of the year’s most sought-after banking assignments. Most Read from BloombergIsrael Says a Cease-Fire Plan Backed by Hamas Falls Far ShortAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeEx-Trump Controller Says Cohen Repaid From Personal AccountJack Dorsey Leaves Bluesky B
